Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Biomedical company announces restructuring management agreement, retains Experigen
December 22nd, 2005
Genesis Bioventures, Inc., (GBIW) (GBI) announced that it has retained Experigen Management Co. to lead its reorganization and restructuring. Experigen's founder, Douglas C. Lane, an executive with over 30 years' experience in pharmaceutical, biotechnology, diagnostics, and technology companies, will work closely with GBI's board of directors and officers to develop and execute the plan. "Mr. Lane's management of business development and mergers and acquisitions at SmithKline Beecham (now GlaxoSmithKline), his interim board experience at Human Genome Sciences, the IPO [initial public offering] development at Hyseq Corp. (now Nuvelo), and his recent...
Source: Women's Health Weekly (2005-12-22)
|
